Cardiol Therapeutics Inc. (TSX:CRDL)
2.700
-0.170 (-5.92%)
Aug 28, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 315.42 million as of August 28, 2026. Its market cap has increased by 141.48% in one year.
Market Cap
315.42M
Enterprise Value
289.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.70
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 315.42M, an increase of 234.43%. That is a compound annual growth rate of 16.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 315.42M | 141.95% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Canopy Growth | 592.25M |
| Verano Holdings | 590.14M |
| Cresco Labs | 400.64M |
| Aurora Cannabis | 361.28M |
| Cipher Pharmaceuticals | 359.88M |
| Auxly Cannabis Group | 332.42M |
| TerrAscend | 284.44M |
| Organigram Global | 236.50M |